Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study
about
Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial AsthmaPersonalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.Optimizing management of chronic obstructive pulmonary disease in the upcoming decade.Systematic review of the evidence relating FEV1 decline to giving up smokingDeaths from nonmalignant respiratory disease in styrene-exposed workers: does obliterative bronchiolitis contribute to mortality?Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims dataDifferential expression of vitamin E and selenium-responsive genes by disease severity in chronic obstructive pulmonary diseaseCo-morbidities are the key nominators of the health related quality of life in mild and moderate COPD.Advanced therapies for COPD-What's on the horizon? Progress in lung volume reduction and lung transplantationSmoking cessation can improve quality of life among COPD patients: validation of the clinical COPD questionnaire into GreekPredicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer.Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study.Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.Carotid endarterectomy in asymptomatic patients with limited life expectancy.Effect of Radix Stemonae concentrated decoction on the lung tissue pathology and inflammatory mediators in COPD ratsContribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes.Adherence to GOLD guideline treatment recommendations among pulmonologists in TurkeyEarly and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease ExacerbationIdentification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance.The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationaleInflammatory biomarkers predicting prognosis in patients with acute dyspneaMicrosimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.Diagnosis of chronic obstructive pulmonary disease in the primary care settingThe disease burden of chronic obstructive pulmonary disease in Greece.Body mass index, airflow obstruction and dyspnea and body mass index, airflow obstruction, dyspnea scores, age and pack years-predictive properties of new multidimensional prognostic indices of chronic obstructive pulmonary disease in primary care.Risk assessment of readmissions following an initial COPD-related hospitalization.Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model.Impact of inhalation therapy on oral health.The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives.Cross-Sectional Study of Chronic Obstructive Pulmonary Disease Prevalence Among Smokers, Ex-Smokers, and Never-Smokers in Almaty, Kazakhstan: Study Protocol.Stratification of telehealthcare for patients with chronic obstructive pulmonary disease using a predictive algorithm as decision support: A pilot study.Chronic respiratory diseases and quality of life in elderly nursing home residents.Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, CanadaImproving hip fractures outcomes for COPD patients.Roy's adaptation model-guided education for adaptation to chronic obstructive pulmonary disease.Survival and mortality following TBI.Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.Role of BMI, airflow obstruction, St George's Respiratory Questionnaire and age index in prognostication of Asian COPD.
P2860
Q26780553-0C4B3128-3770-41DF-9357-8466D03964F7Q27336183-78709DA5-DA58-4BF0-BE95-D12C301746DEQ27693341-C3B6448C-9F86-4DD6-8FF9-EADB41C88001Q28385603-6A4FAD68-0458-47DC-81FC-A57F75F9CB54Q29417854-BCD8EE49-6AF6-4A6B-935F-701A58FF3D7BQ30620671-D78BE487-1638-489F-A11C-35781E963DE5Q30822043-877C83C4-27B9-4F7C-AE14-CB7926A7AFD4Q33766550-E5F66ABB-2AD6-4F41-A5E1-2FC4703F228EQ34500895-67B45770-D18A-4954-9FA6-9B05C7563AEEQ34628616-4595F908-18B7-4CE7-AA30-9775CADB4296Q34633721-CB949E9F-DDB6-4731-AF69-277B000A648EQ35558808-A28D3C22-FE91-4DB5-AAA6-C649EF04EE26Q35870672-3FF40DD4-3B8D-4673-B337-8A25BD86DC45Q35915157-3542E149-A06E-4E30-B27F-A16D55F5DEF1Q35933786-3885A929-A506-496D-AFD4-59A074930DFEQ36060454-D73F7073-31A7-4CD4-8EEB-8490D21B905BQ36189249-CAF711AD-4385-4CF5-8FF5-E8A849B004E9Q36237935-C6A696C4-CF51-40C4-97E7-1BD97FB18F0BQ36390663-E5574F0D-5D65-46DE-B46B-00957FC285F5Q36490109-5750B825-88EA-4A21-8FFA-D96179F8994EQ36581576-FA616A69-F19C-4AA4-8F53-24B895822913Q36752114-465B201A-DD14-44A6-8DBD-53EC875F7F68Q36761565-26AA9E15-22A0-412D-B3D3-1AC0C3081478Q37044288-1E45AB26-D25D-48FB-B095-0022712E04EAQ37082651-E6C63234-E0B4-4043-9FE0-009422AA4580Q37259433-50F77781-F08A-49F5-BF93-42164F404349Q37350573-26F6DFD2-B9FE-45C2-920D-4C7CB5903FC0Q37359282-00FC5093-FED8-4970-8763-56596E6E1822Q37730578-879C16B7-9414-4116-AAC1-0BBAC914DC12Q37956301-A2ACB512-36C7-4075-BC1E-51083C607AE8Q37979254-0D930FA7-C39C-42A2-BCD0-2F25FF525A99Q38372859-0D41007F-B67B-49AD-902B-F6173A7B10F6Q38880640-D553AFF7-CA13-4572-9353-A1DE19A3CDE8Q40860561-BA9C40D7-E323-4430-9992-59AA27C8EDBAQ41877868-2D65779B-8BC6-4E9F-8E7B-34FC5D252707Q46226194-C0A71518-F2BD-43B0-B18A-C537A4F15189Q46279982-48B69905-DC1E-41A9-B6E9-724FE2A8773CQ47376134-0C188F7D-4EF0-4E84-AC11-0F5E288AA8FDQ47661714-4AFC7AFF-1345-4CC5-82F8-8E8C26DC9964Q47665614-29F945E2-FD68-4CB9-B62F-CA0E7E613004
P2860
Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Life expectancy and years of l ...... the NHANES III Follow-up Study
@en
Life expectancy and years of l ...... he NHANES III Follow-up Study.
@nl
type
label
Life expectancy and years of l ...... the NHANES III Follow-up Study
@en
Life expectancy and years of l ...... he NHANES III Follow-up Study.
@nl
prefLabel
Life expectancy and years of l ...... the NHANES III Follow-up Study
@en
Life expectancy and years of l ...... he NHANES III Follow-up Study.
@nl
P2093
P2860
P356
P1476
Life expectancy and years of l ...... the NHANES III Follow-up Study
@en
P2093
David J Strauss
David M Mannino
Robert M Shavelle
Scott J Kush
P2860
P304
P356
10.2147/COPD.S5237
P407
P577
2009-04-15T00:00:00Z